Users Online: 1095
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML

Using 2 nd generation tyrosine kinase inhibitors in frontline management of chronic phase chronic myeloid leukemia

Jayakar Vishal

Year : 2014| Volume: 3| Issue : 1 | Page no: 87-91

   This article has been cited by
 
1 Association of T315I mutation with resistance to tyrosine kinase inhibitor therapy in patients with CML attended the Oncology-Hematology center in Al-Najaf city of Iraq
Rahem Mahdy Rahem,Adel Abdulhussien Abuhmood,Luwaa Hussein
Karbala International Journal of Modern Science. 2017;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article